The firm will now offer Pink’s range of training and consulting for the medical device industry, spanning technology in clinical trial planning, product development, and quality management system audits.
Following the merger the company has already formed the NSF-DBA Medical Device Diploma program which equips medical device professionals with knowledge on quality management and regulatory affairs.
It is the first time NSF-DBA has been offer an “end-to-end” range of services to the medical device industry.
“Our clients continue to face complex technologies and regulatory frameworks with an increased focus on scientific validation and clinical evidence and therefore must rely on professional services to help guide and educate them,” said James Pink, founder of Pink who now joins NSF as partner.
“Integrating our services with NSF-DBA will broaden our capabilities and position us as the experts to help establish our clients’ development and regulatory plans as well as address their product and process validation needs ultimately leading to the assurance to enter their global markets.”